Invesco Pharmaceuticals ETF
Invesco Exchange-Traded Fund Trust
+35
New
35
Positions
| # | Name | Ticker | Since | Shares | Value | % Port | Cat |
|---|---|---|---|---|---|---|---|
| 1 | Invesco Private Prime Fund | N/A | Apr 2025 | 39,432,164 | $39.4M | 16.18% | STIV |
| 2 | Invesco Private Government Fund | N/A | Apr 2025 | 15,157,838 | $15.2M | 6.22% | STIV |
| 3 | Eli Lilly and Co. | 532457108 | Apr 2025 | 14,374 | $12.9M | 5.30% | EC |
| 4 | Abbott Laboratories | 002824100 | Apr 2025 | 95,410 | $12.5M | 5.12% | EC |
| 5 | AbbVie Inc. | 00287Y109 | Apr 2025 | 63,477 | $12.4M | 5.08% | EC |
| 6 | Gilead Sciences, Inc. | 375558103 | Apr 2025 | 116,189 | $12.4M | 5.08% | EC |
| 7 | Johnson & Johnson | 478160104 | Apr 2025 | 78,031 | $12.2M | 5.00% | EC |
| 8 | Merck & Co., Inc. | 58933Y105 | Apr 2025 | 141,755 | $12.1M | 4.96% | EC |
| 9 | Amgen Inc. | 031162100 | Apr 2025 | 41,058 | $11.9M | 4.90% | EC |
| 10 | Pfizer Inc. | 717081103 | Apr 2025 | 484,686 | $11.8M | 4.85% | EC |
| 11 | ANI Pharmaceuticals, Inc. | 00182C103 | Apr 2025 | 129,656 | $9.2M | 3.77% | EC |
| 12 | Tarsus Pharmaceuticals, Inc. | 87650L103 | Apr 2025 | 171,215 | $8.9M | 3.65% | EC |
| 13 | Corcept Therapeutics Inc. | 218352102 | Apr 2025 | 115,420 | $8.3M | 3.40% | EC |
| 14 | Pacira Biosciences, Inc. | 695127100 | Apr 2025 | 281,650 | $7.6M | 3.11% | EC |
| 15 | Innoviva, Inc. | 45781M101 | Apr 2025 | 392,090 | $7.3M | 3.01% | EC |
| 16 | Perrigo Co. PLC | G97822103 | Apr 2025 | 280,307 | $7.2M | 2.96% | EC |
| 17 | Travere Therapeutics, Inc. | 89422G107 | Apr 2025 | 342,340 | $7.1M | 2.92% | EC |
| 18 | Supernus Pharmaceuticals, Inc. | 868459108 | Apr 2025 | 215,467 | $7.0M | 2.87% | EC |
| 19 | Collegium Pharmaceutical, Inc. | 19459J104 | Apr 2025 | 245,226 | $6.6M | 2.72% | EC |
| 20 | Prestige Consumer Healthcare Inc. | 74112D101 | Apr 2025 | 80,925 | $6.6M | 2.70% | EC |
| 21 | Ligand Pharmaceuticals Inc. | 53220K504 | Apr 2025 | 59,553 | $6.5M | 2.68% | EC |
| 22 | Liquidia Corp. | 53635D202 | Apr 2025 | 457,562 | $6.4M | 2.62% | EC |
| 23 | Amneal Pharmaceuticals, Inc. | 03168L105 | Apr 2025 | 831,470 | $6.4M | 2.61% | EC |
| 24 | Bristol-Myers Squibb Co. | 110122108 | Apr 2025 | 121,412 | $6.1M | 2.50% | EC |
| 25 | United Therapeutics Corp. | 91307C102 | Apr 2025 | 19,772 | $6.0M | 2.46% | EC |
| 26 | Biogen Inc. | 09062X103 | Apr 2025 | 49,263 | $6.0M | 2.45% | EC |
| 27 | Jazz Pharmaceuticals PLC | G50871105 | Apr 2025 | 50,617 | $5.9M | 2.43% | EC |
| 28 | Regeneron Pharmaceuticals, Inc. | 75886F107 | Apr 2025 | 9,771 | $5.9M | 2.40% | EC |
| 29 | Harmony Biosciences Holdings, Inc. | 413197104 | Apr 2025 | 191,161 | $5.6M | 2.31% | EC |
| 30 | Amphastar Pharmaceuticals, Inc. | 03209R103 | Apr 2025 | 220,915 | $5.4M | 2.21% | EC |
| 31 | Viatris Inc. | 92556V106 | Apr 2025 | 615,800 | $5.2M | 2.13% | EC |
| 32 | Geron Corp. | 374163103 | Apr 2025 | 2,981,732 | $4.2M | 1.72% | EC |
| 33 | Invesco Government & Agency Portfolio | 825252885 | Apr 2025 | 272,687 | $273K | 0.11% | STIV |
| 34 | OmniAb Operations, Inc. | 68218J202 | Apr 2025 | 39,023 | $0 | 0.00% | EC |
| 35 | OmniAb Operations, Inc. | 68218J301 | Apr 2025 | 39,023 | $0 | 0.00% | EC |